Skip to main content

Home/ medindia/ Group items tagged CNS

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
med india

Crigler-Najjar Syndrome-Causes-Risk Factors-Symptoms-Diagnosis-Treatment-Complications ... - 0 views

www.medindia.net/...crigler-najjar-syndrome.htm

Crigler-Najjar syndrome type 1 2 arias pathological jaundice race age cause enzyme deficiency glucuronosyl transferase autosomal recessive CNS medindia

shared by med india on 04 Nov 11 - No Cached
  • med india on 04 Nov 11
     
    Crigler-Najjar syndrome arises due to the lack or deficiency of the enzyme uridine diphosphate glucuronosyl transferase. Type 1 and type 2 forms of the disease have been described.
Alex Parker

Actavis to settle patent litigation of Daytrana with Noven Pharmaceuticals - 1 views

otc.pharmaceutical-business-review.com/...pharmaceuticals-200314-4200767

health news medical pharma

shared by Alex Parker on 24 Mar 14 - No Cached
  • Alex Parker on 24 Mar 14
     
    PBR Staff Writer Published 20 March 2014 Ireland-based specialty pharmaceutical firm Actavis has entered into an agreement with Noven Pharmaceuticals to settle all outstanding patent litigation related to its generic version of Daytrana (Methylphenidate Transdermal System). Daytrana is a CNS stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.
1 - 2 of 2
Showing 20▼ items per page